Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2026-05-13 19:42:35 ET · period of report 2026-05-11 · accession 0001741987-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-13 19:42 | 2026-05-11 | ARQT | Burnett Patrick | See Remarks | S - Sale | $21.05 | -222 | 120.2K | -0.2% | -$4,673 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-11 | S | D | 222 | $21.05 | 120,244 | D | — | — | (F1) The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. |